Close

Lilly (LLY) and Incyte's (INCY) Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study

Go back to Lilly (LLY) and Incyte's (INCY) Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 56.97 -0.15 (0.26%)
Previous Close $57.12    52 Week High $118.49 
Open $57.25    52 Week Low $55.00 
Day High $57.09    P/E N/A 
Day Low $56.77    EPS $-0.56 
Volume 1,883,242       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 777.96 -0.22 (0.03%)
Previous Close $778.18    52 Week High $88.16 
Open $780.32    52 Week Low $67.88 
Day High $793.67    P/E 180.08 
Day Low $776.44    EPS $4.32 
Volume 3,209,069